Protalix BioTherapeutics Competitors and Similar CompaniesClear all

Protalix BioTherapeutics's competitors and similar companies include Pharming Group.
Protalix BioTherapeutics
Protalix BioTherapeutics
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins.
Pharming Group
Pharming Group
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
Founding Date
Founding Date
1994
Founding Date
1988
Type
Type
Public
Type
Public
Tags
Locations
Locations
Karmiel, IL HQ
Locations
Leiden, NL HQ
Leiden, NL
Employees
Employees
213
Employees
404

Financial

Revenue (est.)
Revenue (est.)
$52.7m (FY, 2025)
Revenue (est.)
$376.1m (FY, 2025)
Cost of goods
Cost of goods
$25.5m (FY, 2025)
Cost of goods
$41.6m (FY, 2025)
Gross profit
Gross profit
$27.2m (FY, 2025)
Gross profit
$341m (FY, 2025)
Net income
Net income
($6.6m) (FY, 2025)
Net income
$2.5m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Pharming Group
HQ
Leiden, NL
Employees
404

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.

View company